Mr Perry T Walters, MD in Bountiful, UT - Urology

Mr Perry T Walters, MD is a Urology physician based in Bountiful, Utah. Mr Perry T Walters is licensed to practice in Utah (license number 1545581205) and his current practice location is 425 Medical Dr, Suite 112, Bountiful, Utah. He can be reached at his office (for appointments etc.) via phone at (801) 292-7249.

NPI number for Mr Perry T Walters is 1790844165 and his current mailing address is 425 Medical Dr, Suite 112, Bountiful, Utah. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1790844165.

Contact Information

	Mr Perry T Walters, MD
	425 Medical Dr, Suite 112, Bountiful, UT 84010
	(801) 292-7249
	(801) 292-7251

Physician's Profile

Full Name	Mr Perry T Walters
Gender	Male
Speciality	Urology
Location	425 Medical Dr, Bountiful, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1790844165
Provider Enumeration Date: 12/08/2006
Last Update Date: 07/18/2008

Medical Identifiers

Medical identifiers for Mr Perry T Walters such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1790844165	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	1545581205 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Perry T Walters is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Perry T Walters, MD 425 Medical Dr, Suite 112, Bountiful, UT 84010 Ph: (801) 292-7249	Mr Perry T Walters, MD 425 Medical Dr, Suite 112, Bountiful, UT 84010 Ph: (801) 292-7249

News Archive

People with severe emphysema may breathe better after EBV therapy, study shows

People with severe emphysema may breathe better after a minimally invasive procedure that places valves in the airways leading to diseased portions of their lungs, according to a randomized, controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

Integra LifeSciences releases FDA cleared Total Wrist Fusion System

Integra LifeSciences Holdings Corporation announced today the release of the Integra™ Total Wrist Fusion System, a solution for wrist arthrodesis that is designed to provide fixation of the wrist while decreasing soft tissue irritation. The system provides an optimal balance of compression and stability by combining the Surfix® locking technology and dynamic compression.

Genous Bio-engineered R stent beneficial for patients not suitable for long term DAPT

OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.

R-Tech Ueno enrolls retinitis pigmentosa patients in Phase 3 clinical study of UF-021 ophthalmic solution

R-Tech Ueno is pleased to announce the start of the patient enrollment of a Phase 3 clinical study with Unoprostone (development code UF-021) ophthalmic solution that are being developed in our company for the treatment of retinitis pigmentosa.

Researchers uncover how small heat shock protein interacts with other proteins

In Alzheimer's disease proteins clump together to long fibrils causing the death of nerve cells. Small heat shock proteins can counteract this effect. Scientists, therefore, hope to deploy them as agents in the treatment of neurodegenerative diseases. Using the example of a small heat shock protein, researchers at the Technical University of Munich and the Helmholtz Zentrum Muenchen have now uncovered how the protein interacts with other proteins.

Urology Doctors in Bountiful, UT

David J Henderson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 620 Medical Dr Ste 150, Bountiful, UT 84010 Phone: 801-298-3247 Fax: 801-298-9675
Justin Paul Parkinson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr, Suite 370, Bountiful, UT 84010 Phone: 801-965-3600

Mr Perry T Walters, MD - Urology in Bountiful, UT